Recombinant Human C17orf35 Protein，GST

C17orf35, located on chromosome 17, has garnered attention in recent years due to its potential implications in various biological processes and diseases. Initially identified through genomics studies, this gene encodes a protein that is hypothesized to play a role in cellular functions such as cell proliferation, differentiation, and apoptosis. Research has indicated that C17orf35 may be involved in certain pathological conditions, including cancer, where its expression levels appear to correlate with tumorigenesis and patient prognosis. Furthermore, studies have suggested that variations in the C17orf35 gene could be linked to specific genetic disorders, prompting further investigation into its functional mechanisms. The production of recombinant C17orf35 protein offers a unique opportunity to explore its structure and function in detail, enabling researchers to dissect its biological roles and interactions with other cellular components. Understanding C17orf35 at the molecular level could provide insights into its contributions to disease processes, paving the way for the development of novel therapeutic strategies. Given the current advancements in protein engineering and expression systems, the study of C17orf35 in recombinant form has the potential to unlock crucial information about its biological significance and pave the way for innovative approaches in addressing diseases associated with this gene.